Capricorn Fund Managers Ltd
Source: SEC Form 13F · as of Mar 2026Capricorn Fund Managers Ltd holds 14 biotech & pharma companies tracked by BioSniper, totaling $108.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$108.5M
| Company | Shares | Value |
|---|---|---|
| ZYMEZymeworks Inc. | 1,007,210 | $25.2M |
| ADPTAdaptive Biotechnologies Corp | 1,291,773 | $17.9M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 267,045 | $14.8M |
| ELVNEnliven Therapeutics, Inc. | 369,400 | $14.5M |
| LQDALiquidia Corp | 247,405 | $9.3M |
| FOLDAMICUS THERAPEUTICS, INC. | 534,079 | $7.7M |
| ABBVAbbVie Inc. | 27,397 | $6.0M |
| PFEPFIZER INC | 165,730 | $4.7M |
| VERAVera Therapeutics, Inc. | 64,604 | $2.6M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 202,900 | $1.9M |
| TARSTarsus Pharmaceuticals, Inc. | 26,000 | $1.8M |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | 339,727 | $961K |
| CAHCardinal Health Inc. | 2,813 | $594K |
| ROIVRoivant Sciences Ltd. | 20,000 | $554K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.